{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:29:10Z","timestamp":1791685750747,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autism Spectrum Disorder (ASD) is one of the most common neurodevelopmental disorders with no drugs treating the core symptoms and no validated biomarkers for clinical use. The multi-functional phytochemical sulforaphane affects many of the biochemical abnormalities associated with ASD. We investigated potential molecular markers from three ASD-associated physiological pathways that can be affected by sulforaphane: redox metabolism\/oxidative stress; heat shock response; and immune dysregulation\/inflammation, in peripheral blood mononuclear cells (PBMCs) from healthy donors and patients with ASD. We first analyzed the mRNA levels of selected molecular markers in response to sulforaphane <jats:italic>ex vivo<\/jats:italic> treatment in PBMCs from healthy donors by real-time quantitative PCR. All of the tested markers showed quantifiability, accuracy and reproducibility. We then compared the expression levels of those markers in PBMCs taken from ASD patients in response to orally-delivered sulforaphane. The mRNA levels of cytoprotective enzymes (NQO1, HO-1, AKR1C1), and heat shock proteins (HSP27 and HSP70), increased. Conversely, mRNA levels of pro-inflammatory markers (IL-6, IL-1\u03b2, COX-2 and TNF-\u03b1) decreased. Individually none is sufficiently specific or sensitive, but when grouped by function as two panels, these biomarkers show promise for monitoring pharmacodynamic responses to sulforaphane in both healthy and autistic humans, and providing guidance for biomedical interventions.<\/jats:p>","DOI":"10.1038\/s41598-020-62714-4","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T10:04:52Z","timestamp":1585821892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Biomarker Exploration in Human Peripheral Blood Mononuclear Cells for Monitoring Sulforaphane Treatment Responses in Autism Spectrum Disorder"],"prefix":"10.1038","volume":"10","author":[{"given":"Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew W.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwaljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Diggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine K.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albena T.","family":"Dinkova-Kostova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed W.","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"62714_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","volume":"67","author":"J Baio","year":"2018","unstructured":"Baio, J. et al. Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill. Summ. 67, 1\u201323 (2018).","journal-title":"MMWR Surveill. Summ."},{"key":"62714_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fped.2014.00066","volume":"2","author":"RE Frye","year":"2014","unstructured":"Frye, R. E. & Rossignol, D. A. Treatments for biomedical abnormalities associated with autism spectrum disorder. Front. Pediatr 2, 66 (2014).","journal-title":"Front. Pediatr"},{"key":"62714_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fpsyt.2014.00100","volume":"5","author":"AA Goldani","year":"2014","unstructured":"Goldani, A. A., Downs, S. R., Widjaja, F., Lawton, B. & Hendren, R. L. Biomarkers in autism. Front. Psychiatry 5, 100 (2014).","journal-title":"Front. Psychiatry"},{"key":"62714_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.psyneuen.2017.12.022","volume":"89","author":"O Oztan","year":"2018","unstructured":"Oztan, O. et al. Biomarker discovery for disease status and symptom severity in children with autism. Psychoneuroendocrinology 89, 39\u201345 (2018).","journal-title":"Psychoneuroendocrinology"},{"key":"62714_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-030-05542-4_11","volume":"1118","author":"L Shen","year":"2019","unstructured":"Shen, L. et al. Advances in biomarker studies in autism spectrum disorders. Adv. Exp. Med. Biol. 1118, 207\u2013233 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"62714_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1871527315666160413120414","volume":"15","author":"H Liu","year":"2016","unstructured":"Liu, H., Talalay, P. & Fahey, J. W. Biomarker-guided strategy for treatment of autism spectrum disorder (ASD). CNS Neurol. Disord. Drug Targets 15, 602\u2013613 (2016).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"62714_CR7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10803-014-2225-4","volume":"45","author":"GM Anderson","year":"2015","unstructured":"Anderson, G. M. Autism biomarkers: challenges, pitfalls and possibilities. J. Autism Dev. Disord. 45, 1103\u20131113 (2015).","journal-title":"J. Autism Dev. Disord."},{"key":"62714_CR8","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1073\/pnas.89.6.2399","volume":"89","author":"Y Zhang","year":"1992","unstructured":"Zhang, Y., Talalay, P., Cho, C. G. & Posner, G. H. A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc. Natl. Acad. Sci. U.S.A. 89, 2399\u20132403 (1992).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"62714_CR9","doi-asserted-by":"publisher","first-page":"10367","DOI":"10.1073\/pnas.94.19.10367","volume":"94","author":"JW Fahey","year":"1997","unstructured":"Fahey, J. W., Zhang, Y. & Talalay, P. Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 94, 10367\u201310372 (1997).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"62714_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0031-9422(00)00316-2","volume":"56","author":"JW Fahey","year":"2001","unstructured":"Fahey, J. W., Zalcmann, A. T. & Talalay, P. The chemical diversity and distribution of glucosinolates and isothiocyanates among plants. Phytochemistry 56, 5\u201351 (2001).","journal-title":"Phytochemistry"},{"key":"62714_CR11","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1158\/1940-6207.CAPR-11-0538","volume":"5","author":"JW Fahey","year":"2012","unstructured":"Fahey, J. W. et al. Protection of humans by plant glucosinolates: efficiency of conversion of glucosinolates to isothiocyanates by the gastrointestinal microflora. Cancer. Prev. Res. (Phila) 5, 603\u2013611 (2012).","journal-title":"Cancer. Prev. Res. (Phila)"},{"key":"62714_CR12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1745-7254.2007.00679.x","volume":"28","author":"Y Zhang","year":"2007","unstructured":"Zhang, Y. & Tang, L. Discovery and development of sulforaphane as a cancer chemopreventive phytochemical. Acta Pharmacol. Sin. 28, 1343\u20131354 (2007).","journal-title":"Acta Pharmacol. Sin."},{"key":"62714_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tifs.2017.02.002","volume":"69","author":"AT Dinkova-Kostova","year":"2017","unstructured":"Dinkova-Kostova, A. T., Fahey, J. W., Kostov, R. V. & Kensler, T. W. KEAP1 and done? Targeting the NRF2 pathway with sulforaphane. Trends Food Sci. Technol. 69, 257\u2013269 (2017).","journal-title":"Trends Food Sci. Technol."},{"key":"62714_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/MCO.0000000000000511","volume":"21","author":"AA Panjwani","year":"2018","unstructured":"Panjwani, A. A., Liu, H. & Fahey, J. W. Crucifers and related vegetables and supplements for neurologic disorders: what is the evidence? Curr. Opin. Clin. Nutr. Metab. Care 21, 451\u2013457 (2018).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"62714_CR15","doi-asserted-by":"publisher","unstructured":"Yagishita, Y., Fahey, J. W., Dinkova-Kostova, A. T. & Kensler, T. W. Broccoli or sulforaphane: is it the source or dose that matters? Molecules 24, 3593;\u00a0https:\/\/doi.org\/10.3390\/molecules24193593 (2019).","DOI":"10.3390\/molecules24193593"},{"key":"62714_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/17460441.2019.1621285","volume":"14","author":"KK Chadman","year":"2019","unstructured":"Chadman, K. K., Fernandes, S., DiLiberto, E. & Feingold, R. Do animal models hold value in Autism spectrum disorder (ASD) drug discovery? Expert Opin. Drug Discov. 14, 727\u2013734 (2019).","journal-title":"Expert Opin. Drug Discov."},{"key":"62714_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.phrs.2018.08.022","volume":"139","author":"OEF Shaw","year":"2019","unstructured":"Shaw, O. E. F. & Yager, J. Y. Preventing childhood and lifelong disability: Maternal dietary supplementation for perinatal brain injury. Pharmacol. Res. 139, 228\u2013242 (2019).","journal-title":"Pharmacol. Res."},{"key":"62714_CR18","doi-asserted-by":"publisher","first-page":"15550","DOI":"10.1073\/pnas.1416940111","volume":"111","author":"K Singh","year":"2014","unstructured":"Singh, K. et al. Sulforaphane treatment of autism spectrum disorder (ASD). Proc. Natl. Acad. Sci. U.S.A. 111, 15550\u201315555 (2014).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"62714_CR19","doi-asserted-by":"crossref","unstructured":"Lynch, R. et al. Sulforaphane from broccoli reduces symptoms of autism: a follow-up case series from a randomized double-blind study. Glob. Adv. Health. Med. 6, 2164957X17735826 (2017).","DOI":"10.1177\/2164957X17735826"},{"key":"62714_CR20","doi-asserted-by":"publisher","first-page":"415078","DOI":"10.1155\/2013\/415078","volume":"2013","author":"A Tarozzi","year":"2013","unstructured":"Tarozzi, A. et al. Sulforaphane as a potential protective phytochemical against neurodegenerative diseases. Oxid Med. Cell. Longev. 2013, 415078 (2013).","journal-title":"Oxid Med. Cell. Longev."},{"key":"62714_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes, J. D. & Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39, 199\u2013218 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"62714_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1254\/jphs.10257FP","volume":"115","author":"K Mizuno","year":"2011","unstructured":"Mizuno, K. et al. Glutathione biosynthesis via activation of the nuclear factor E2-related factor 2 (Nrf2)\u2013antioxidant-response element (ARE) pathway is essential for neuroprotective effects of sulforaphane and 6-(methylsulfinyl) hexyl isothiocyanate. J. Pharmacol. Sci. 115, 320\u2013328 (2011).","journal-title":"J. Pharmacol. Sci."},{"key":"62714_CR23","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1523\/JNEUROSCI.3817-03.2004","volume":"24","author":"AD Kraft","year":"2004","unstructured":"Kraft, A. D., Johnson, D. A. & Johnson, J. A. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J. Neurosci. 24, 1101\u20131112 (2004).","journal-title":"J. Neurosci."},{"key":"62714_CR24","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.freeradbiomed.2013.08.182","volume":"65","author":"M Negrette-Guzman","year":"2013","unstructured":"Negrette-Guzman, M., Huerta-Yepez, S., Tapia, E. & Pedraza-Chaverri, J. Modulation of mitochondrial functions by the indirect antioxidant sulforaphane: a seemingly contradictory dual role and an integrative hypothesis. Free Radic. Biol. Med. 65, 1078\u20131089 (2013).","journal-title":"Free Radic. Biol. Med."},{"key":"62714_CR25","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1089\/neu.2012.2474","volume":"29","author":"AL Benedict","year":"2012","unstructured":"Benedict, A. L. et al. Neuroprotective effects of sulforaphane after contusive spinal cord injury. J. Neurotrauma 29, 2576\u20132586 (2012).","journal-title":"J. Neurotrauma"},{"key":"62714_CR26","doi-asserted-by":"publisher","first-page":"32008","DOI":"10.1074\/jbc.M104794200","volume":"276","author":"E Heiss","year":"2001","unstructured":"Heiss, E., Herhaus, C., Klimo, K., Bartsch, H. & Gerhauser, C. Nuclear factor kappa B is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms. J. Biol. Chem. 276, 32008\u201332015 (2001).","journal-title":"J. Biol. Chem."},{"key":"62714_CR27","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"NG Innamorato","year":"2008","unstructured":"Innamorato, N. G. et al. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 181, 680\u2013689 (2008).","journal-title":"J. Immunol."},{"key":"62714_CR28","doi-asserted-by":"crossref","unstructured":"Egea, J., Gonzalez-Rodriguez, A., Gomez-Guerrero, C. & Moreno, J. A. Editorial: Role of Nrf2 in disease: novel molecular mechanisms and therapeutic. Front. Pharmacol 10, 1149 (2019).","DOI":"10.3389\/fphar.2019.01149"},{"key":"62714_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00204-011-0674-5","volume":"85","author":"L Baird","year":"2011","unstructured":"Baird, L. & Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 85, 241\u2013272 (2011).","journal-title":"Arch. Toxicol."},{"key":"62714_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","volume":"18","author":"A Cuadrado","year":"2019","unstructured":"Cuadrado, A. et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug Discov. 18, 295\u2013317 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62714_CR31","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1096\/fasebj.9.7.7737461","volume":"9","author":"RJ Reiter","year":"1995","unstructured":"Reiter, R. J. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J. 9, 526\u2013533 (1995).","journal-title":"FASEB J."},{"key":"62714_CR32","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","volume":"285","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova, A. T., Kostov, R. V. & Kazantsev, A. G. The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J. 285, 3576\u20133590 (2018).","journal-title":"FEBS J."},{"key":"62714_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.exger.2015.11.004","volume":"73","author":"BE Townsend","year":"2016","unstructured":"Townsend, B. E. & Johnson, R. W. Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice. Exp. Gerontol. 73, 42\u201348 (2016).","journal-title":"Exp. Gerontol."},{"key":"62714_CR34","doi-asserted-by":"publisher","first-page":"3549274","DOI":"10.1155\/2019\/3549274","volume":"2019","author":"L Subedi","year":"2019","unstructured":"Subedi, L., Cho, K., Park, Y. U., Choi, H. J. & Kim, S. Y. Sulforaphane-enriched broccoli sprouts pretreated by pulsed electric fields reduces neuroinflammation and ameliorates scopolamine-induced amnesia in mouse brain through its antioxidant ability via Nrf2-HO-1 activation. Oxid Med. Cell. Longev 2019, 3549274 (2019).","journal-title":"Oxid Med. Cell. Longev"},{"key":"62714_CR35","doi-asserted-by":"publisher","first-page":"15926","DOI":"10.1073\/pnas.0808346105","volume":"105","author":"H Liu","year":"2008","unstructured":"Liu, H., Dinkova-Kostova, A. T. & Talalay, P. Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles. Proc. Natl. Acad. Sci. U. S. A. 105, 15926\u201315931 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"62714_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.canlet.2008.04.018","volume":"269","author":"JD Clarke","year":"2008","unstructured":"Clarke, J. D., Dashwood, R. H. & Ho, E. Multi-targeted prevention of cancer by sulforaphane. Cancer Lett. 269, 291\u2013304 (2008).","journal-title":"Cancer Lett."},{"key":"62714_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1208\/s12248-009-9162-8","volume":"12","author":"KL Cheung","year":"2010","unstructured":"Cheung, K. L. & Kong, A. N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 12, 87\u201397 (2010).","journal-title":"AAPS J."},{"key":"62714_CR38","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/sj.bjc.6604703","volume":"99","author":"S Nair","year":"2008","unstructured":"Nair, S., Doh, S. T., Chan, J. Y., Kong, A. N. & Cai, L. Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis. Br. J. Cancer 99, 2070\u20132082 (2008).","journal-title":"Br. J. Cancer"},{"key":"62714_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat. Commun. 7, 11624 (2016).","journal-title":"Nat. Commun."},{"key":"62714_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113\u2013117 (2018).","journal-title":"Nature"},{"key":"62714_CR41","doi-asserted-by":"publisher","first-page":"e1386","DOI":"10.1542\/peds.2007-0360","volume":"120","author":"LK Curran","year":"2007","unstructured":"Curran, L. K. et al. Behaviors associated with fever in children with autism spectrum disorders. Pediatrics 120, e1386\u201392 (2007).","journal-title":"Pediatrics"},{"key":"62714_CR42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.brainresrev.2008.11.001","volume":"59","author":"MF Mehler","year":"2009","unstructured":"Mehler, M. F. & Purpura, D. P. Autism, fever, epigenetics and the locus coeruleus. Brain Res. Rev. 59, 388\u2013392 (2009).","journal-title":"Brain Res. Rev."},{"key":"62714_CR43","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-1843-6","volume":"577","author":"MD Reed","year":"2020","unstructured":"Reed, M. D. et al. IL-17a promotes sociability in mouse models of neurodevelopmental disorders. Nature 577, 249\u2013253 (2020).","journal-title":"Nature"},{"key":"62714_CR44","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.chembiol.2011.09.008","volume":"18","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y. et al. HSF1-dependent upregulation of Hsp70 by sulfhydryl-reactive inducers of the KEAP1\/NRF2\/ARE pathway. Chem. Biol. 18, 1355\u20131361 (2011).","journal-title":"Chem. Biol."},{"key":"62714_CR45","first-page":"606104","volume":"2012","author":"AT Dinkova-Kostova","year":"2012","unstructured":"Dinkova-Kostova, A. T. The role of sulfhydryl reactivity of small molecules for the activation of the KEAP1\/NRF2 pathway and the heat shock response. Scientifica (Cairo) 2012, 606104 (2012).","journal-title":"Scientifica (Cairo)"},{"key":"62714_CR46","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1093\/hmg\/dds247","volume":"21","author":"RD Brose","year":"2012","unstructured":"Brose, R. D. et al. Activation of the stress proteome as a mechanism for small molecule therapeutics. Hum. Mol. Genet. 21, 4237\u20134252 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"62714_CR47","doi-asserted-by":"publisher","first-page":"35528","DOI":"10.1074\/jbc.M110.152686","volume":"285","author":"N Gan","year":"2010","unstructured":"Gan, N. et al. Sulforaphane activates heat shock response and enhances proteasome activity through up-regulation of Hsp27. J. Biol. Chem. 285, 35528\u201335536 (2010).","journal-title":"J. Biol. Chem."},{"key":"62714_CR48","doi-asserted-by":"publisher","first-page":"9590","DOI":"10.1073\/pnas.1004104107","volume":"107","author":"YH Ahn","year":"2010","unstructured":"Ahn, Y. H. et al. Electrophilic tuning of the chemoprotective natural product sulforaphane. Proc. Natl. Acad. Sci. U.S.A. 107, 9590\u20139595 (2010).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"62714_CR49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan, A. & Chauhan, V. Oxidative stress in autism. Pathophysiology 13, 171\u2013181 (2006).","journal-title":"Pathophysiology"},{"key":"62714_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol, D. A. & Frye, R. E. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol. Psychiatry 17, 389\u2013401 (2012).","journal-title":"Mol. Psychiatry"},{"key":"62714_CR51","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fphys.2014.00150","volume":"5","author":"DA Rossignol","year":"2014","unstructured":"Rossignol, D. A. & Frye, R. E. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol 5, 150 (2014).","journal-title":"Front. Physiol"},{"key":"62714_CR52","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler, T. W., Wakabayashi, N. & Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47, 89\u2013116 (2007).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"62714_CR53","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/128_2012_339","volume":"329","author":"TW Kensler","year":"2013","unstructured":"Kensler, T. W. et al. Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane. Top. Curr. Chem 329, 163\u2013177 (2013).","journal-title":"Top. Curr. Chem"},{"key":"62714_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1196\/annals.1391.032","volume":"1113","author":"IR Brown","year":"2007","unstructured":"Brown, I. R. Heat shock proteins and protection of the nervous system. Ann. N. Y. Acad. Sci. 1113, 147\u2013158 (2007).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"62714_CR55","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/carcin\/bgm049","volume":"28","author":"BS Cornblatt","year":"2007","unstructured":"Cornblatt, B. S. et al. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis 28, 1485\u20131490 (2007).","journal-title":"Carcinogenesis"},{"key":"62714_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0009-8981(01)00727-6","volume":"316","author":"L Ye","year":"2002","unstructured":"Ye, L. et al. Quantitative determination of dithiocarbamates in human plasma, serum, erythrocytes and urine: pharmacokinetics of broccoli sprout isothiocyanates in humans. Clin. Chim. Acta 316, 43\u201353 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"62714_CR57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jneuroim.2008.12.002","volume":"207","author":"X Li","year":"2009","unstructured":"Li, X. et al. Elevated immune response in the brain of autistic patients. J. Neuroimmunol. 207, 111\u2013116 (2009).","journal-title":"J. Neuroimmunol."},{"key":"62714_CR58","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W. & Pardo, C. A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57, 67\u201381 (2005).","journal-title":"Ann. Neurol."},{"key":"62714_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/jamapsychiatry.2013.272","volume":"70","author":"K Suzuki","year":"2013","unstructured":"Suzuki, K. et al. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70, 49\u201358 (2013).","journal-title":"JAMA Psychiatry"},{"key":"62714_CR60","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jneuroim.2010.10.025","volume":"232","author":"P Ashwood","year":"2011","unstructured":"Ashwood, P. et al. Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J. Neuroimmunol. 232, 196\u2013199 (2011).","journal-title":"J. Neuroimmunol."},{"key":"62714_CR61","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood, P. et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 25, 40\u201345 (2011).","journal-title":"Brain Behav. Immun."},{"key":"62714_CR62","doi-asserted-by":"publisher","first-page":"72-2094","DOI":"10.1186\/1742-2094-10-72","volume":"10","author":"LY Al-Ayadhi","year":"2013","unstructured":"Al-Ayadhi, L. Y. & Mostafa, G. A. Elevated serum levels of macrophage-derived chemokine and thymus and activation-regulated chemokine in autistic children. J. Neuroinflammation 10, 72-2094\u201310-72 (2013).","journal-title":"J. Neuroinflammation"},{"key":"62714_CR63","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mcn.2012.10.003","volume":"53","author":"AM Depino","year":"2013","unstructured":"Depino, A. M. Peripheral and central inflammation in autism spectrum disorders. Mol. Cell. Neurosci. 53, 69\u201376 (2013).","journal-title":"Mol. Cell. Neurosci."},{"key":"62714_CR64","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/mp.2014.59","volume":"20","author":"A Masi","year":"2015","unstructured":"Masi, A. et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol. Psychiatry 20, 440\u2013446 (2015).","journal-title":"Mol. Psychiatry"},{"key":"62714_CR65","doi-asserted-by":"publisher","first-page":"e19488","DOI":"10.1371\/journal.pone.0019488","volume":"6","author":"US Naik","year":"2011","unstructured":"Naik, U. S. et al. A study of nuclear transcription factor-kappa B in childhood autism. PLoS One 6, e19488 (2011).","journal-title":"PLoS One"},{"key":"62714_CR66","first-page":"3775","volume":"55","author":"CS Custodio","year":"2018","unstructured":"Custodio, C. S. et al. Neonatal immune challenge with lipopolysaccharide triggers long-lasting sex- and age-related behavioral and immune\/neurotrophic alterations in mice: relevance to autism spectrum disorders. Mol. Neurobiol. 55, 3775\u20133788 (2018).","journal-title":"Mol. Neurobiol."},{"key":"62714_CR67","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1207\/s15327914nc5501_7","volume":"55","author":"TA Shapiro","year":"2006","unstructured":"Shapiro, T. A. et al. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study. Nutr. Cancer 55, 53\u201362 (2006).","journal-title":"Nutr. Cancer"},{"key":"62714_CR68","doi-asserted-by":"publisher","first-page":"e0140963","DOI":"10.1371\/journal.pone.0140963","volume":"10","author":"JW Fahey","year":"2015","unstructured":"Fahey, J. W. et al. Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase. PLoS One 10, e0140963 (2015).","journal-title":"PLoS One"},{"key":"62714_CR69","doi-asserted-by":"publisher","unstructured":"Fahey, J. W. et al. Bioavailability of sulforaphane following ingestion of glucoraphanin-rich broccoli sprout and seed extracts with active myrosinase: a pilot study of the effects of proton pump inhibitor administration. Nutrients 11, 1489;\u00a0https:\/\/doi.org\/10.3390\/nu11071489 (2019).","DOI":"10.3390\/nu11071489"},{"key":"62714_CR70","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/jn\/137.7.1718","volume":"137","author":"AV Gasper","year":"2007","unstructured":"Gasper, A. V. et al. Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa. J. Nutr 137, 1718\u20131724 (2007).","journal-title":"J. Nutr"},{"key":"62714_CR71","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/carcin\/bgp176","volume":"30","author":"AK MacLeod","year":"2009","unstructured":"MacLeod, A. K. et al. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30, 1571\u20131580 (2009).","journal-title":"Carcinogenesis"},{"key":"62714_CR72","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10549-011-1536-9","volume":"132","author":"AS Agyeman","year":"2012","unstructured":"Agyeman, A. S. et al. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Res. Treat. 132, 175\u2013187 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"62714_CR73","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1158\/1541-7786.MCR-13-0330-T","volume":"11","author":"T Ohashi","year":"2013","unstructured":"Ohashi, T., Idogawa, M., Sasaki, Y., Suzuki, H. & Tokino, T. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis. Mol. Cancer. Res. 11, 1554\u20131563 (2013).","journal-title":"Mol. Cancer. Res."},{"key":"62714_CR74","doi-asserted-by":"publisher","first-page":"e1405","DOI":"10.1542\/peds.2013-1545","volume":"133","author":"E Napoli","year":"2014","unstructured":"Napoli, E., Wong, S., Hertz-Picciotto, I. & Giulivi, C. Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 133, e1405\u201310 (2014).","journal-title":"Pediatrics"},{"key":"62714_CR75","doi-asserted-by":"publisher","first-page":"11908","DOI":"10.1073\/pnas.172398899","volume":"99","author":"AT Dinkova-Kostova","year":"2002","unstructured":"Dinkova-Kostova, A. T. et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 99, 11908\u201311913 (2002).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"62714_CR76","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition (DSM-V) (2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"62714_CR77","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"62714_CR78","doi-asserted-by":"publisher","first-page":"19065","DOI":"10.1073\/pnas.1318247110","volume":"110","author":"H Liu","year":"2013","unstructured":"Liu, H. & Talalay, P. Relevance of anti-inflammatory and antioxidant activities of exemestane and synergism with sulforaphane for disease prevention. Proc. Natl. Acad. Sci. U.S.A. 110, 19065\u201319070 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62714-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:12:57Z","timestamp":1670317977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62714"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62714-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5822"}}